研究について 【2013年】

英文原著論文　Original papers

発刊済のものはabstractまたは本文にリンクしてあります。
Published papers are linked to PubMed

Takahashi,T., Maeda,K., Suzuki,T., Ishido,A., Shigeoka,T., Tominaga,T., Kamei,T., Honda,M., Ninomiya,D., Sakai,T., Senba,T., Kaneyuki,S., Sakaguchi,S., Satoh,A., Hosokawa,T., Kawabe,Y., Kurihara,S., Izumikawa,K., Kohno,S., Azuma,T., Suemori,K., Yasukawa,M., Mizutani,T., Omatsu,T., Katayama,Y., Miyahara,M., Ijuin,M., Doi,K., Okuda,M., Umeki,K., Saito,T., Fukushima,K., Nakajima,K., Yoshikawa,T., Tani,H., Fukushi,S., Fukuma,A., Ogata,M., Shimojima,M., Nakajima,N., Nagata,N., Katano,H., Fukumoto,H., Sato,Y., Hasegawa,H., Yamagishi,T., Oishi,K., Kurane,I., Morikawa,S., Saijo,M.

The First Identification and Retrospective Study of Severe Fever with Thrombocytopenia Syndrome in Japan.

J Infect Dis. 2014 Mar;209(6):816-27.

Fujiishi,K., Kitazawa,R., Nagai,Y., Watanabe,T., Bando,K., Kobayashi,S., Yakushijin,Y., Haraguchi,R., Kitazawa,S.

Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.

Virchows Arch. 2014 Jan;464(1):121-4.

Tanimoto,K., Muranski,P., Miner,S., Fujiwara,H., Kajigaya,S., Keyvanfar,K., Hensel,N., Barrett,AJ., Melenhorst,JJ.

Genetically engineered fixed K562 cells: potent “off-the-shelf” antigen-presenting cells for generating virus-specific T cells.

Cytotherapy. 2014 Jan;16(1):135-46.

Ohkubo,N., Suzuki,Y., Aoto,M., Yamanouchi,J., Hirakawa,S., Yasukawa,M., Mitsuda,N.

Accelerated destruction of erythrocytes in Tie2 promoter-driven STAT3 conditional knockout mice.

Life Sci. 2013 Sep 17;93(9-11):380-7. doi: 10.1016/j.lfs.2013.07.025. Epub 2013 Aug 2.

Yamanouchi,J., Hato,T., Niiya,T., Azuma,T., Yasukawa,M.

Severe immune thrombocytopenia secondary to Waldenström’s macroglobulinemia with anti-GPIb/IX monoclonal IgM antibody.

Ann Hematol. 2014 Apr;93(4):711-2.

Matsumoto,T., Hasegawa,H., Onishi,S., Ishizaki,J., Suemori,K., Yasukawa,M.

Protein kinase C inhibitor generates stable human tolerogenic dendritic cells.

J Immunol. 2013 Sep 1;191(5):2247-57. doi: 10.4049/jimmunol.1203053. Epub 2013 Jul 22.

Nagai,K., Ochi,F., Terui,K., Maeda,M., Ohga,S., Kanegane,H., Kitoh,T., Kogawa,K., Suzuki,N., Ohta,S., Ishida,Y., Okamura,T., Wakiguchi,H., Yasukawa,M., Ishii,E.

Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan.

Pediatr Blood Cancer. 2013 Oct;60(10):1582-6. doi: 10.1002/pbc.24637. Epub 2013 Jun 27.

Miyazaki,Y., Fujiwara,H., Asai,H., Ochi,F., Ochi,T., Azuma,T., Ishida,T., Okamoto,S., Mineno,J., Kuzushima,K., Shiku,H., Yasukawa,M.

Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.

Blood. 2013 Jun 13;121(24):4894-901. doi: 10.1182/blood-2012-11-465971. Epub 2013 May 2.

Iwami, K., Natsume, A., Ohno, M., Ikeda, H., Mineno, J., Nukaya, I., Okamoto, S., Fujiwara, H., Yasukawa, M., Shiku, H., Wakabayashi, T.

Adoptive transfer of genetically modified Wilms’ tumor 1-specific T cells in a novel malignant skull base meningioma model.

Neuro Oncol. 2013 Jun;15(6):747-58.

Asai, H., Fujiwara, H., An, J., Ochi, T., Miyazaki, Y., Nagai, K., Okamoto, S., Mineno, J., Kuzushima, K., Shiku, H., Inoue, H., Yasukawa, M.

Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor.

PLoS One 8:e56820, 2013.

Yamanouch,i J., Hato, T., Niiya, T., Hayashi, T., Yasukawa, M.

Novel causative and neutral mutations in a patient with protein C deficiency.

Thromb Res. 2013 May;131(5):466-8.

Shikata, H., Yakushijin, Y., Yamanouchi, J., Azuma, T., Yasukawa, M.

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.

Int J Clin Oncol. 2014 Feb;19(1):178-85.

Miyazaki, Y., Nawa, Y., Miyagawa, M., Kohashi, S., Nakase, K., Yasukawa, M., Hara, M.

Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.

Ann Hematol. 92:239-244, 2013.